| Date Filed | Type | Description |
| 08/07/2023 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 117,272 shares
@ $2.539, valued at
$297.8k
Sold 150,000 shares
@ $2.4992, valued at
$374.9k
Sold 8,616 shares
@ $2.4679, valued at
$21.3k
|
|
| 08/03/2023 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 105,944 shares
@ $2.679, valued at
$283.8k
Sold 73,704 shares
@ $2.593, valued at
$191.1k
|
|
| 05/03/2023 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 455,536 shares
@ $2.5759, valued at
$1.2M
|
|
| 02/03/2023 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 432,928 shares
@ $2.5572, valued at
$1.1M
|
|
| 12/21/2022 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 600,000 shares
@ $2.116, valued at
$1.3M
|
|
| 11/03/2022 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Paid exercise price by delivering 454,856 shares
@ $1.6, valued at
$727.8k
Sold 32,904 shares
@ $1.6726, valued at
$55k
|
|
| 09/28/2022 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 3,600,000 shares
@ $0 |
|
| 08/11/2022 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 600,000 shares
@ $1.75, valued at
$1.1M
|
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 32,904 shares
@ $0.4956, valued at
$16.3k
|
|
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 334,448 shares
@ $0.7475, valued at
$250k
Paid exercise price by delivering 288,648 shares
@ $0.7763, valued at
$224.1k
Sold 52,056 shares
@ $0.7256, valued at
$37.8k
|
|
| 11/03/2021 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Paid exercise price by delivering 454,848 shares
@ $0.64, valued at
$291.1k
Sold 52,056 shares
@ $0.6411, valued at
$33.4k
|
|
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| ZACCARDELLI DAVID (President & CEO) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 5,275 shares
@ $27.9, valued at
$147.2k
|
|
| 07/03/2019 |
4
| ZACCARDELLI DAVID (President & CEO) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 5,899 shares
@ $15.73, valued at
$92.8k
Sold 4,551 shares
@ $16.22, valued at
$73.8k
|
|
| 06/12/2019 |
4
| ZACCARDELLI DAVID (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 12/21/2018 |
4
| ZACCARDELLI DAVID (President & CEO) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Granted 82,372 shares
@ $0
Bought 10,000 shares
@ $6.07, valued at
$60.7k
Granted 1,000,000 options to buy
@ $6.07, valued at
$6.1M
|
|
| 12/20/2018 |
3
| ZACCARDELLI DAVID (President & CEO) has filed a Form 3 on Dova Pharmaceuticals Inc. |
| 06/14/2018 |
4
| ZACCARDELLI DAVID (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 25,000 options to buy
@ $7.45, valued at
$186.3k
Granted 9,100 options to buy
@ $7.45, valued at
$67.8k
|
|
| 05/31/2018 |
4
| ZACCARDELLI DAVID (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Bought 40,000 shares
@ $5, valued at
$200k
|
|
| 12/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/12/2016 |
4
| ZACCARDELLI DAVID (Director) has filed a Form 4 on CEMPRA, INC.|
Txns:
| Granted 25,000 options to buy
@ $22.77, valued at
$569.3k
|
|
| 06/27/2016 |
4
| ZACCARDELLI DAVID (Former EVP and COO) has filed a Form 4 on UNITED THERAPEUTICS Corp |
| 03/15/2016 |
4
| ZACCARDELLI DAVID (EVP & COO) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Granted 73,500 options
@ $120.26, valued at
$8.8M
|
|